Pharming To Branch Out Into Japan With Leniolisib Following Successful Pivotal Trial

 
• By Ayisha Sharma

The Dutch firm has announced its intention to submit US and EU filings for leniolisib and expand development into Japan after the candidate impressed in an ultra-rare disease study.  

Mt. Fuji with Shinkansen train and rice field at Shizuoka, Japan.
Pharming Is Considering Japan As Leniolisib Provides An Opportunity To Broaden Scope. • Source: Alamy

More from Clinical Trials

More from R&D